Mayo Finds Little Evidence that DTC Tests Stir Risk Worries | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Genetic tests sold directly to consumers that provide predictions on disease risk have made some personalized medicine watchers wary that these tests could cause unnecessary psychological stress and worry among customers about their risk of disease, but a new study from Mayo Clinic suggests that those worries may be minimal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.